Project Details
Description
Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer
| Status | Active |
|---|---|
| Effective start/end date | 4/1/24 → 3/31/27 |
Funding
- THOMAS JEFFERSON UNIVERSITY
- NIH NATIONAL CANCER INSTITUTE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.